267 related articles for article (PubMed ID: 31271801)
1. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
[TBL] [Abstract][Full Text] [Related]
2. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitory activity of methoxy-substituted chalcones.
Mathew B; Mathew GE; Ucar G; Joy M; Nafna EK; Lohidakshan KK; Suresh J
Int J Biol Macromol; 2017 Nov; 104(Pt A):1321-1329. PubMed ID: 28577983
[TBL] [Abstract][Full Text] [Related]
4. Monoamine Oxidase Inhibitory Activity: Methyl- versus Chlorochalcone Derivatives.
Mathew B; Uçar G; Mathew GE; Mathew S; Kalatharakkal Purapurath P; Moolayil F; Mohan S; Varghese Gupta S
ChemMedChem; 2016 Dec; 11(24):2649-2655. PubMed ID: 27902880
[TBL] [Abstract][Full Text] [Related]
5. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
[TBL] [Abstract][Full Text] [Related]
6. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
[TBL] [Abstract][Full Text] [Related]
7. Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors.
Sudevan ST; Oh JM; Abdelgawad MA; Abourehab MAS; Rangarajan TM; Kumar S; Ahmad I; Patel H; Kim H; Mathew B
Sci Rep; 2022 Dec; 12(1):22404. PubMed ID: 36575270
[TBL] [Abstract][Full Text] [Related]
8. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
Zarmouh NO; Eyunni SK; Soliman KF
BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
[TBL] [Abstract][Full Text] [Related]
9. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H
Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752
[TBL] [Abstract][Full Text] [Related]
10. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
[TBL] [Abstract][Full Text] [Related]
11. Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B.
Oh JM; Jang HJ; Kim WJ; Kang MG; Baek SC; Lee JP; Park D; Oh SR; Kim H
Int J Biol Macromol; 2020 May; 151():441-448. PubMed ID: 32087226
[TBL] [Abstract][Full Text] [Related]
12. Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A.
Baek SC; Park MH; Ryu HW; Lee JP; Kang MG; Park D; Park CM; Oh SR; Kim H
Bioorg Chem; 2019 Mar; 83():317-325. PubMed ID: 30396116
[TBL] [Abstract][Full Text] [Related]
13. Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors.
Mathew B; Haridas A; Uçar G; Baysal I; Adeniyi AA; Soliman ME; Joy M; Mathew GE; Lakshmanan B; Jayaprakash V
Int J Biol Macromol; 2016 Oct; 91():680-95. PubMed ID: 27262516
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones.
Parambi DGT; Aljoufi F; Murugaiyah V; Mathew GE; Dev S; Lakshminarayanan B; Hendawy OM; Mathew B
Cent Nerv Syst Agents Med Chem; 2019; 19(1):67-71. PubMed ID: 30451121
[TBL] [Abstract][Full Text] [Related]
15. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
[TBL] [Abstract][Full Text] [Related]
16. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO-B Inhibitors.
Mathew B; Haridas A; Uçar G; Baysal I; Joy M; Mathew GE; Lakshmanan B; Jayaprakash V
ChemMedChem; 2016 Jun; 11(11):1161-71. PubMed ID: 27159243
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B.
Kong Z; Sun D; Jiang Y; Hu Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1513-1523. PubMed ID: 32705910
[TBL] [Abstract][Full Text] [Related]
19. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
20. Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.
Mathew B; Baek SC; Thomas Parambi DG; Lee JP; Mathew GE; Jayanthi S; Vinod D; Rapheal C; Devikrishna V; Kondarath SS; Uddin MS; Kim H
Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800309. PubMed ID: 30663112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
